Please login to the form below
New Accounts: March
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period January 2006 to February 2006 inclusive
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period January 2006 to February 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
|
|
 |
 |
 |
|
Astellas |
Pan-European corporate profiling |
Corporate |
The Choice Group |
|
AstraZeneca |
Crestor |
Cardiovascular |
Zaicom MMC |
|
Boehringer Ingelheim/Lilly UK |
Cymbalta |
Neurology |
Virgo Health PR |
|
Cephalon |
Actiq |
Pain |
TVF Communications |
|
GE Healthcare Europe |
DaTSCAN |
Diagnostic/neurology |
Succinct Communications |
|
GlaxoSmithKline |
Kivexa |
HIV |
90TEN Healthcare |
|
GlaxoSmithKline |
New product |
Oncology |
Succinct Communications |
|
Novartis |
Aclasta |
CRM |
MRM Worldwide |
|
Novartis |
Diovan/Codiovan |
Hypertension |
TVF Communications |
|
Novartis |
OTC |
Skincare products |
Toniq |
|
Novartis |
Prexige |
Osteoarthritic pain |
Clew Communications |
|
Pfizer |
5th Ann Meet of Institute of Arthritis & Pain |
Arthritis and pain |
Zaicom MMC |
|
Pfizer |
Diovan/Codiovan |
Hypertension |
TVF Communications |
|
Pfizer |
Vfend |
Haematology |
Zaicom MMC |
|
Sankyo |
Olmetec |
Hypertension |
Athena Medical PR |
|
UCB Pharma |
Equasym XL |
ADHD |
TVF Communications |
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trial
- A new era for patient services?
- New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell
- Roche’s Tecentriq combo scores FDA approval for melanoma
- Moderna looks to price COVID-19 vaccine at $50-$60 per course
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- AbbVie, Amgen and Takeda team up for joint COVID-19 trial
- Sanofi faces manslaughter allegations in France over Depakine deaths
- Introducing Porterhouse Intelligence Hub
- Medical Device Clinical Trials 2020
- Article: What's next? How behavioural science can support pharma's future
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
- Article: What's next? How behavioural science can support pharma's future
- ...
- Video: UX/ Experience design research
- ...
Quick links
Infographics
